However, treatment with different doses of QCS and SASP suppressed the increased levels of TNF-α (QCS-L group: 947.54 ± 23.63; QCS-M group: 874.51 ± 21.38; QCS-H group: 852.87 ± 22.44; SASP group: 854.51± 25.66) and IL-6 (QCS-M group: 79.01 ± 12.56; QCS-H group: 83.37 ± 10.17; SASP group: 68.29 ± 8.49) in DSS-induced colitis. This evidence concerns the gene TNF and colitis.